Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NECLIFE | NSE
-1.02
-2.09%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
47.86
48.01
50.09
47.11
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime cefuroxime axetil amorphous cefuroxime axetil crystalline cefotaxime sodium ceftriaxone sodium cefixime trihydrate cefuroxime axetil cefpodoxime proxetil and sterile cefprozil cefdinir cefuroxime sodium cefazolin sodium ceftazidime pentahydrate and cefepime +Arginine. The company also offers contract manufacturing for finished dosage forms such as tablets capsules dry powder oral suspensions and granules and injectable for cephalosporins. In addition it provides phytochemicals and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh India.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
107.5%1 month
95.1%3 months
64.5%6 months
59.8%201.62
-
1.10
0.59
0.29
10.36
1.09
-
1.58B
11.03B
131.76M
-
6.78
62.50
-8.90
0.47
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
19.50
Range1M
27.18
Range3M
29.00
Rel. volume
0.32
Price X volume
95.94M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 399.15 | 11.15B | 4.16% | n/a | 119.57% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 410.1 | 10.85B | 0.05% | 53.99 | 4.77% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1481.35 | 8.45B | -1.90% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 256.19 | 8.40B | 1.93% | 16.51 | 416.89% |
Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 140.34 | 8.29B | -0.64% | 2.10 | 1.78% |
Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 376.85 | 6.10B | -2.89% | 50.24 | 17.95% |
Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 476.5 | 6.01B | -0.31% | 72.99 | 15.37% |
SAKAR | SAKAR | Drug Manufacturers-Specialty & Generic | 327.15 | 5.67B | -2.26% | 65.31 | 30.25% |
Zim Laboratories Limited | ZIMLAB | Drug Manufacturers-Specialty & Generic | 113.3 | 5.56B | -1.26% | 31.56 | 45.58% |
Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 350.65 | 4.71B | -0.67% | 17.16 | 8.48% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.1 | 306.88M | -0.20% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.36 | - | Cheaper |
Ent. to Revenue | 1.09 | - | Cheaper |
PE Ratio | 201.62 | 47.84 | Expensive |
Price to Book | 1.10 | 6.55 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 64.46 | - | Riskier |
Debt to Equity | 0.59 | 0.34 | Expensive |
Debt to Assets | 0.29 | 0.17 | Expensive |
Market Cap | 11.03B | - | Emerging |